ZYBT · Company research
Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 1.11 | $81,915,273.37 | 81792273.37 | — | — | — | — | 2.2931323377750406 | 30.81359047147707980021 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.